2-hydroxy-5-nitrobenzylthioguanosine has been researched along with 5-iodotubercidin in 1 studies
| Studies (2-hydroxy-5-nitrobenzylthioguanosine) | Trials (2-hydroxy-5-nitrobenzylthioguanosine) | Recent Studies (post-2010) (2-hydroxy-5-nitrobenzylthioguanosine) | Studies (5-iodotubercidin) | Trials (5-iodotubercidin) | Recent Studies (post-2010) (5-iodotubercidin) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 140 | 0 | 42 |
| Protein | Taxonomy | 2-hydroxy-5-nitrobenzylthioguanosine (IC50) | 5-iodotubercidin (IC50) |
|---|---|---|---|
| Chain A, Mitogen-activated protein kinase 3 | Homo sapiens (human) | 0.9 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.2 | |
| Adenosine kinase | Homo sapiens (human) | 0.1583 | |
| Adenosine kinase | Mycobacterium tuberculosis H37Rv | 1.2 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.071 | |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buolamwini, JK; Zhu, Z | 1 |
1 other study(ies) available for 2-hydroxy-5-nitrobenzylthioguanosine and 5-iodotubercidin
| Article | Year |
|---|---|
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Topics: Drug Design; Equilibrative Nucleoside Transporter 1; Glycosides; Humans; K562 Cells; Models, Biological; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Static Electricity; Thioinosine | 2008 |